TC BioPharm Shares Halted On Circuit Breaker ; Stock Trading Lower During The Company's Shareholder Update Conference Call
TC BioPharm Shares Halted On Circuit Breaker ; Stock Trading Lower During The Company's Shareholder Update Conference Call
Conference Call to be held on Tuesday, February 21st, 2023 at Noon ET
电话会议将于美国东部时间2023年2月21日星期二中午举行
EDINBURGH, Scotland, Feb. 13, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced that it now plans to host its shareholder update call on Tuesday, February 21, 2023, at 12:00 p.m. ET. The call was originally scheduled for Monday, February 20, 2023, at 10:00 a.m. ET.
苏格兰爱丁堡,2023年2月13日 /PRNewswire/ — TC BioPharm(Holdings)PLC(“TC BioPharm” 或 “公司”)(纳斯达克股票代码:TCBP)(纳斯达克股票代码:TCBPW)今天宣布,现在计划在美国东部时间2023年2月21日星期二中午12点举行股东更新电话会议。该电话会议原定于美国东部时间2023年2月20日星期一上午10点举行。
Management intends to provide a comprehensive update on the Company's clinical trial plan for its allogeneic gamma delta therapeutic in oncology indications as well as insight on the company's 2023 outlook and discuss business development efforts. The Company intends to provide a forum for Q&A after opening remarks from senior management.
管理层打算全面介绍该公司针对肿瘤适应症的异体伽玛三角洲疗法的临床试验计划的最新情况,以及对公司2023年展望的见解,并讨论业务发展工作。公司打算在高级管理层致开幕词后提供一个问答论坛。
The Company will answer pre-submitted questions. Investors are asked to submit their questions to IR@tcbiopharm.com
公司将回答预先提交的问题。要求投资者将问题提交到 IR@tcbiopharm.com
Conference Call Information: | |
Date: | Tuesday, February 21, 2023 |
Time: | 12:00 pm Eastern Time |
Live Call: | 1-877-704-4453 (U.S. Toll-Free) or 1-201-389-0920 (International) |
Webcast: |
电话会议信息: | |
日期: | 2023年2月21日,星期二 |
时间: | 美国东部时间下午 12:00 |
实时通话: | 1-877-704-4453(美国免费电话)或 1-201-389-0920(国际) |
网络直播: |